Diabetes drug linked to increased bladder cancer risk

01 Apr 2016


A new study of 145,806 people who took pioglitazone compared to other oral diabetes drugs showed that it raises the risk of bladder cancer by 63%. Results were published in the BMJ.

NHS Direct


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story